SYRS - Syros Pharmaceuticals Q2 2024 Earnings Preview
2024-07-30 12:47:29 ET
More on Syros Pharmaceuticals
- Syros Pharmaceuticals: Entering A Decisive Era With An Expected 2024 Phase 3 Readout
- Syros Pharmaceuticals, Inc. (SYRS) Q1 2024 Earnings Call Transcript
- Syros Pharmaceuticals GAAP EPS of -$0.10 beats by $0.77
- Syros Pharmaceuticals Q1 2024 Earnings Preview
- Seeking Alpha’s Quant Rating on Syros Pharmaceuticals